Evaluation of the predictive power of this novel signature in silico on an ICI-treated melanoma patient cohort extracted from GEO and EGA databases, revealed WFDC1, EFNA3, DDX10, and PTBP1 as marker genes. The gene discussed is EFNA3; the disease is melanoma.